When a pharmaceutical company tells you that its drug is
safer than it really is, it probably plays with your health. And possibly with
your life. That's not a very nice thing to do. But it's also very profitable. Which
is why it happens more often that you care to know.
Our best bet for healthy aging is to escape the flawed health care system. It makes disease treatment more profitable than prevention. It neglects aging as a treatable cause of diseases. And it denies access to personalized lifestyle medicine. This blog is about how you can overcome these limitations. It is about challenging half-truths and outdated ideas. It is focused on evidence-based, personalized lifestyle medicine for lifelong health. Delivered by a feisty public health scientist.
Showing posts with label Finance. Show all posts
Showing posts with label Finance. Show all posts
Monday, May 14, 2012
Why your heart attack may just be collateral damage in big pharma's turf wars.
Labels:
Actos,
Avandia,
Cleveland clinics,
diabetes,
Finance,
GlaxoSmithKline,
health,
heart attack,
life,
Nissen,
Pioglitazone,
Rosiglitazone,
Senate Committee,
Takeda
Location:
Baden-Baden, Deutschland
Subscribe to:
Posts (Atom)